(Q53081345)

11 May 2018

title

Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. (English)

1 reference

11 May 2018

author name string

Ziqiang Li

1

1 reference

11 May 2018

Mei Tang

2

1 reference

11 May 2018

Bo Ling

3

1 reference

11 May 2018

Shiying Liu

4

1 reference

11 May 2018

Yu Zheng

5

1 reference

11 May 2018

Chunlai Nie

6

1 reference

11 May 2018

Zhu Yuan

7

1 reference

11 May 2018

Liangxue Zhou

8

1 reference

11 May 2018

Gang Guo

9

1 reference

11 May 2018

Aiping Tong

10

1 reference

11 May 2018

Yuquan Wei

11

1 reference

11 May 2018

publication date

27 November 2013

1 reference

11 May 2018

Journal of Molecular Medicine

published in

1 reference

11 May 2018

volume

92

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

291-303

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00109-013-1104-3

exact match

0 references

cites work

Crystal structures of S100A6 in the Ca(2+)-free and Ca(2+)-bound states: the calcium sensor mechanism of S100 proteins revealed at atomic resolution

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

The S100 family of EF-hand calcium-binding proteins: functions and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Calcyclin as a marker of human epithelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100P promotes pancreatic cancer growth, survival, and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Molecular mechanisms of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Specific expression of osteopontin and S100A6 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

S100P dissociates myosin IIA filaments and focal adhesion sites to reduce cell adhesion and enhance cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Structure of the S100A6 Complex with a Fragment from the C-Terminal Domain of Siah-1 Interacting Protein: A Novel Mode for S100 Protein Target Recognition † ‡

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Oncogenic beta-catenin signaling networks in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-013-1104-3

Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas

21 January 2018

1 reference

12 December 2020

Structural and functional analysis of a growth-regulated gene, the human calcyclin

1 reference

12 December 2020

High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients

1 reference

12 December 2020

Expression of S100A2 and S100A6 in thyroid carcinomas

1 reference

12 December 2020

10.1007/S00109-013-1104-3

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018